# Ifosfamide-Induced Partial Arginine Vasopressin Resistance Responsive to Vasopressin/Desmopressin and Amiloride

**Authors:** Nicholas Ma, Haley Wilt, Patrick Donabedian, Shirley Kim

PMC · DOI: 10.7759/cureus.83897 · Cureus · 2025-05-11

## TL;DR

A patient developed partial vasopressin resistance after chemotherapy, which improved with vasopressin, desmopressin, and amiloride.

## Contribution

Demonstrates a novel treatment approach for chemotherapy-induced vasopressin resistance using vasopressin, desmopressin, and amiloride.

## Key findings

- Polyuria and hypernatremia occurred after chemotherapy with doxorubicin-ifosfamide-mesna.
- Treatment with vasopressin, desmopressin, and amiloride improved symptoms.
- Elevated plasma copeptin confirmed partial arginine vasopressin resistance.

## Abstract

This is a case of partial arginine vasopressin resistance following the sixth cycle of doxorubicin-ifosfamide-mesna therapy for recurrent spindle cell sarcoma of the thigh. Polyuria and symptomatic hypernatremia started by the second day of the two-day chemotherapy cycle. The diagnosis was confirmed with serum and urine chemistry testing showing urine hypo-osmolality (161 mOsm/kg) with polyuria (4.8 L urine output) in 24 hours, serum hyperosmolality (355 mOsm/kg), and an elevated baseline plasma copeptin of 82 pmol/L. Treatment with intravenous vasopressin followed by amiloride and supraphysiologic doses of oral desmopressin improved symptomatic hypernatremia.

## Linked entities

- **Proteins:** avp (arginine vasopressin)
- **Chemicals:** doxorubicin (PubChem CID 31703), ifosfamide (PubChem CID 3690), mesna (PubChem CID 23662354), vasopressin (PubChem CID 8230), desmopressin (PubChem CID 5311065), amiloride (PubChem CID 16231)
- **Diseases:** spindle cell sarcoma (MONDO:0002927)

## Full-text entities

- **Diseases:** spindle cell sarcoma (MESH:D012509), Polyuria (MESH:D011141), hypernatremia (MESH:D006955)
- **Chemicals:** Ifosfamide (MESH:D007069), doxorubicin (MESH:D004317), mesna (MESH:D015080), copeptin (MESH:C048197), Amiloride (MESH:D000584)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12151266/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12151266/full.md

## References

13 references — full list in the complete paper: https://tomesphere.com/paper/PMC12151266/full.md

---
Source: https://tomesphere.com/paper/PMC12151266